|
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison |
Baji P, Pentek M, Czirjak L, Szekanecz Z, Nagy G, Gulacsi L, Brodszky V |
|
|
Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Baji P, Pentek M, Czirjak L, Szekanecz Z, Nagy G, Gulacsi L, Brodszky V. Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison. European Journal of Health Economics 2014; 15(Supplement 1): S53-S64 Indexing Status Subject indexing assigned by NLM MeSH Antibodies, Monoclonal /adverse effects /therapeutic use; Antirheumatic Agents /adverse effects /therapeutic use; Arthritis, Rheumatoid /drug therapy; Biological Factors /adverse effects /therapeutic use; Biosimilar Pharmaceuticals /adverse effects /therapeutic use; Humans; Infliximab; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome AccessionNumber 12014034243 Date bibliographic record published 16/09/2014 |
|
|
|